The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Functionalization of Platinum Complexes for Biomedical Applications
Abstract
Platinum-based anticancer drugs are the mainstay of chemotherapy regimens in clinic. Nevertheless, the efficacy of platinum drugs is badly affected by serious systemic toxicities and drug resistance, and the pharmacokinetics of most platinum drugs is largely unknown. In recent years, a keen interest in functionalizing platinum complexes with bioactive molecules, targeting groups, photosensitizers, fluorophores, or nanomaterials has been sparked among chemical and biomedical researchers. The motivation for functionalization comes from some of the following demands: to improve the tumor selectivity or minimize the systemic toxicity of the drugs, to enhance the cellular accumulation of the drugs, to overcome the tumor resistance to the drugs, to visualize the drug molecules in vitro or in vivo, to achieve a synergistic anticancer effect between different therapeutic modalities, or to add extra functionality to the drugs. In this Account, we present different strategies being used for functionalizing platinum complexes, including conjugation with bisphosphonates, peptides, receptor-specific ligands, polymers, nanoparticles, magnetic resonance imaging contrast agents, metal chelators, or photosensitizers. Among them, bisphosphonates, peptides, and receptor-specific ligands are used for actively targeted drug delivery, polymers and nanoparticles are for passively targeted drug delivery, magnetic resonance imaging contrast agents are for theranostic purposes, metal chelators are for the treatment or prevention of Alzheimer's disease (AD), and photosensitizers are for photodynamic therapy of cancers. The rationales behind these designs are explained and justified at the molecular or cellular level, associating with the requirements for diagnosis, therapy, and visualization of biological processes. To illustrate the wide range of opportunities and challenges that are emerging in this realm, representative examples of targeted drug delivery systems, anticancer conjugates, anticancer theranostic agents, and anti-AD compounds relevant to functionalized platinum complexes are provided. All the examples exhibit new potential of platinum complexes for future applications in biomedical areas. The emphases of this Account are placed on the functionalization for targeted drug delivery and theranostic agents. In the end, a general assessment of various strategies has been made according to their major shortcomings and defects. The original information in this Account comes entirely from literature appearing since 2010.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Effect of Surface Properties on Nanoparticle–Cell Interactions
Verma, A., & Stellacci, F. (2010) · Small · doi:10.1002/smll.200901158 · Cited by 2,619
Gold Nanoparticles for Biology and Medicine
Giljohann, D. A., Seferos, D. S., Daniel, W. L., Massich, M. D., Patel, P. C., & Mirkin, C. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904359 · Cited by 2,356
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
Celli, J. P., Spring, B. Q., Rizvi, I., Evans, C. L., Samkoe, K. S., Verma, S., Pogue, B. W., & Hasan, T. (2010) · Chemical Reviews · doi:10.1021/cr900300p · Cited by 2,324
The status of platinum anticancer drugs in the clinic and in clinical trials
Wheate, N. J., Walker, S., Craig, G. E., & Oun, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00292e · Cited by 1,634
Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles
Hao, R., Xing, R., Xu, Z., Hou, Y., Gao, S., & Sun, S. (2010) · Advanced Materials · doi:10.1002/adma.201000260 · Cited by 1,372
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Brown, S. D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P. R., Venugopal, B., Flint, D. J., Plumb, J. A., Graham, D., & Wheate, N. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908117a · Cited by 865
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Self-citationDai, Y., Xiao, H., Liu, J., Yuan, Q., Ma, P., Yang, D., Li, C., Cheng, Z., Hou, Z., Yang, P., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja410028q · Cited by 529
Silicon Nanomaterials Platform for Bioimaging, Biosensing, and Cancer Therapy
Peng, F., Su, Y., Zhong, Y., Fan, C., Lee, S.-T., & He, Y. (2014) · Accounts of Chemical Research · doi:10.1021/ar400221g · Cited by 491
Yuan, Y., Kwok, R. T. K., Tang, B. Z., & Liu, B. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411811w · Cited by 474
Polymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
Aryal, S., Hu, C.-M. J., & Zhang, L. (2010) · ACS Nano · doi:10.1021/nn9014032 · Cited by 400
Nanocarriers for delivery of platinum anticancer drugs
Oberoi, H. S., Nukolova, N. V., Kabanov, A. V., & Bronich, T. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.014 · Cited by 396
Bioactive Luminescent Transition‐Metal Complexes for Biomedical Applications
Ma, D., He, H., Leung, K., Chan, D. S., & Leung, C. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208414 · Cited by 388
When self-assembly meets biology: luminescent platinum complexes for imaging applications
Mauro, M., Aliprandi, A., Septiadi, D., Kehr, N. S., & De Cola, L. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60453e · Cited by 385
Silica-based nanoprobes for biomedical imaging and theranostic applications
Vivero-Escoto, J. L., Huxford-Phillips, R. C., & Lin, W. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15229k · Cited by 381
Sun, L.-D., Wang, Y.-F., & Yan, C.-H. (2014) · Accounts of Chemical Research · doi:10.1021/ar400218t · Cited by 363
Min, Y., Li, J., Liu, F., Yeow, E. K. L., & Xing, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308834 · Cited by 309
The Use of Therapeutic Peptides to Target and to Kill Cancer Cells
J. Boohaker, R., W. Lee, M., Vishnubhotla, P., M. Perez, J. L., & R. Khaled, A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801661004 · Cited by 302
Advances in Platinum Chemotherapeutics
Harper, B. W., Krause‐Heuer, A. M., Grant, M. P., Manohar, M., Garbutcheon‐Singh, K. B., & Aldrich‐Wright, J. R. (2010) · Chemistry – A European Journal · doi:10.1002/chem.201000148 · Cited by 267
Cho, H.-S., Dong, Z., Pauletti, G. M., Zhang, J., Xu, H., Gu, H., Wang, L., Ewing, R. C., Huth, C., Wang, F., et al. (2010) · ACS Nano · doi:10.1021/nn101000e · Cited by 265
Nanomaterial standards for efficacy and toxicity assessment
Adiseshaiah, P. P., Hall, J. B., & McNeil, S. E. (2010) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.66 · Cited by 238
Drug transporters of platinum-based anticancer agents and their clinical significance
Burger, H., Loos, W. J., Eechoute, K., Verweij, J., Mathijssen, R. H. J., & Wiemer, E. A. C. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2010.12.002 · Cited by 230
Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
Min, Y., Mao, C., Chen, S., Ma, G., Wang, J., & Liu, Y. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201562 · Cited by 222
Visible‐Light‐Induced Annihilation of Tumor Cells with Platinum–Porphyrin Conjugates
Naik, A., Rubbiani, R., Gasser, G., & Spingler, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400533 · Cited by 212
Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
Min, Y., Mao, C., Chen, S., Ma, G., Wang, J., & Liu, Y. (2012) · Angewandte Chemie · doi:10.1002/ange.201201562 · Cited by 181
Targeted Delivery of Cisplatin to Lung Cancer Using ScFvEGFR-Heparin-Cisplatin Nanoparticles
Peng, X.-H., Wang, Y., Huang, D., Wang, Y., Shin, H. J., Chen, Z., Spewak, M. B., Mao, H. Z., Wang, X., Wang, Y., et al. (2011) · ACS Nano · doi:10.1021/nn202410f · Cited by 160
Self-citationWáng, Y. X. J., Zhu, Leung, Lee, Zhao, Wang, Lai, Wan, C., Cheng, C. H. K., & Ahuja, A. T. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28316 · Cited by 145
Kesavan, K. P., Ratliff, J., Johnson, E. W., Dahlberg, W. K., Asara, J. M., Misra, P., Frangioni, J. V., & Jacoby, D. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066092 · Cited by 144
Kaida, S., Cabral, H., Kumagai, M., Kishimura, A., Terada, Y., Sekino, M., Aoki, I., Nishiyama, N., Tani, T., & Kataoka, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0303 · Cited by 136
Paraskar, A. S., Soni, S., Chin, K. T., Chaudhuri, P., Muto, K. W., Berkowitz, J. L., Handlogten, M. W., Alves, N. J., Bilgiçer, B., Dinulescu, D. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007026107 · Cited by 135
Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
Yang, J. J., Sun, X., Mao, W., Sui, M., Tang, J., & Shen, Y. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200597r · Cited by 127
Craig, G. E., Brown, S. D., Lamprou, D. A., Graham, D., & Wheate, N. (2012) · Inorganic Chemistry · doi:10.1021/ic202197g · Cited by 122
Immuno‐Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents
Wong, D. Y. Q., Yeo, C. H. F., & Ang, W. H. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402879 · Cited by 121
Gandioso, A., Shaili, E., Massaguer, A., Artigas, G., González-Cantó, A., Woods, J. A., Sadler, P. J., & Marchán, V. (2015) · Chemical Communications · doi:10.1039/c5cc03180j · Cited by 116
Gd-DTPA-loaded polymer–metal complex micelles with high relaxivity for MR cancer imaging
Mi, P., Cabral, H., Kokuryo, D., Rafi, M., Terada, Y., Aoki, I., Saga, T., Takehiko, I., Nishiyama, N., & Kataoka, K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.030 · Cited by 114
Lau, J. T. F., Lo, P., Fong, W., & Ng, D. K. P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300398q · Cited by 108
Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells
Graf, N., Mokhtari, T. E., Papayannopoulos, I. A., & Lippard, S. J. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.02.012 · Cited by 107
Mitaplatin Increases Sensitivity of Tumor Cells to Cisplatin by Inducing Mitochondrial Dysfunction
Xue, X., You, S., Zhang, Q., Wu, Y. F., Zou, G.-Z., Wang, P. C., Zhao, Y.-L., Xu, Y., Jia, L., Zhang, X., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200571k · Cited by 99
Gold nanorods for platinum based prodrug delivery
Min, Y., Mao, C., Xu, D., Wang, J., & Liu, Y. (2010) · Chemical Communications · doi:10.1039/c0cc03108a · Cited by 95
Patra, C. R., Bhattacharya, R., & Mukherjee, P. (2009) · Journal of Materials Chemistry · doi:10.1039/b913224d · Cited by 94
Zhu, Z., Wang, X., Li, T., Aime, S., Sadler, P. J., & Guo, Z. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201407406 · Cited by 92
Self-citationNano-functionalization of metal complexes for molecular imaging and anticancer therapy
Maldonado, C. R., Salassa, L., Gomez-Blanco, N., & Rivas, J. C. M. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.04.014 · Cited by 87
Inhibitory action of macrocyclic platiniferous chelators on metal-induced Aβ aggregation
Wang, X., Wang, X., Zhang, C., Jiao, Y., & Guo, Z. (2012) · Chemical Science · doi:10.1039/c2sc01100j · Cited by 87
Self-citationValensin, D., Gabbiani, C., & Luigi Messori, A. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.04.010 · Cited by 84
Xue, X., Hall, M. D., Zhang, Q., Wang, P. C., Gottesman, M. M., & Liang, X. (2013) · ACS Nano · doi:10.1021/nn405004f · Cited by 80
Anticancer Platinum (IV) Prodrugs with Novel Modes of Activity
Chin, C. F., Wong, D. Y. Q., Jothibasu, R., & Ang, W. H. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611798040778 · Cited by 80
Liu, L., Ye, Q., Lu, M., Lo, Y.-C., Hsu, Y., Wei, M.-C., Chen, Y.-H., Lo, S., Wang, S.-J., Bain, D. J., et al. (2015) · Scientific Reports · doi:10.1038/srep10881 · Cited by 78
Development of a Platinum Complex as an anti‐Amyloid Agent for the Therapy of Alzheimer’s Disease
Kenche, V. B., Hung, L. W., Perez, K. A., Volitakes, I., Ciccotosto, G., Kwok, J., Critch, N., Sherratt, N., Cortés, M., Lal, V., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209885 · Cited by 77
Iafisco, M., Palazzo, B., Martra, G., Margiotta, N., Piccinonna, S., Natile, G., Gandin, V., Marzano, C., & Roveri, N. (2011) · Nanoscale · doi:10.1039/c1nr11147g · Cited by 76
Koo, C., So, L. K. Y., Wong, K., Ho, Y., Lam, Y. W., Lam, M. H., Cheah, K., Cheng, C. C.-W., & Kwok, W. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200902919 · Cited by 75
Xue, Z., Lin, M., Zhu, J., Zhang, J., Li, Y., & Guo, Z. (2010) · Chemical Communications · doi:10.1039/b922222g · Cited by 73
Self-citationSong, Y., Suntharalingam, K., Yeung, J. S., Royzen, M., & Lippard, S. J. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400281a · Cited by 72
Xing, R., Wang, X., Zhang, C., Wang, J., Zhang, Y., Song, Y., & Guo, Z. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm11369k · Cited by 71
Self-citationMargiotta, N., Denora, N., Ostuni, R., Laquintana, V., Anderson, A. L., Johnson, S. W., Trapani, G., & Natile, G. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100429r · Cited by 66
Gaviglio, L., Groß, A., Metzler‐Nolte, N., & Ravera, M. (2012) · Metallomics · doi:10.1039/c2mt00171c · Cited by 62
Cisplatin Inhibits Protein Splicing, Suggesting Inteins as Therapeutic Targets in Mycobacteria
Zhang, L., Zheng, Y., Callahan, B. P., Belfort, M., & Liu, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.171124 · Cited by 54
Wang, J., Wang, X., Song, Y., Wang, J., Zhang, C., Chang, C., Yan, J., Qiu, L., Wu, M., & Guo, Z. (2013) · Chemical Science · doi:10.1039/c3sc50554e · Cited by 51
Self-citationNew Trends and Future Developments of Platinum‐Based Antitumor Drugs
Wang, X., & Guo, Z. (2011) · Wiley eBooks · doi:10.1002/9783527633104.ch4 · Cited by 33
Self-citationGuo, Z., Tong, W., & Chan, M. C. W. (2013) · Chemical Communications · doi:10.1039/c3cc47150k · Cited by 28
Self-citationDetecting and delivering platinum anticancer drugs using fluorescent maghemite nanoparticles
Wang, J., Wang, X., Song, Y., Zhu, C., Wang, J., Wang, K., & Guo, Z. (2013) · Chemical Communications · doi:10.1039/c3cc39059d · Cited by 23
Self-citationA simple synthesis of a targeted drug delivery system with enhanced cytotoxicity
Bhattacharyya, S., Gonzalez, M., Robertson, J. D., Bhattacharya, R., & Mukherjee, P. (2011) · Chemical Communications · doi:10.1039/c1cc12902c · Cited by 15
Cited by
Encyclopedia of Inorganic and Bioinorganic Chemistry
(2011) · Wiley eBooks · doi:10.1002/9781119951438 · Cited by 1,585
Platinum-based drugs for cancer therapy and anti-tumor strategies
Zhang, C., Xu, C., Gao, X., & Yao, Q. (2022) · Theranostics · doi:10.7150/thno.69424 · Cited by 1,018
Zhou, J., Yu, G., & Huang, F. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00898d · Cited by 677
Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04269 · Cited by 649
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Self-citation
Metadata
- Authors
- Wang, X., Wang, X., & Guo, Z.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-08-06
- Volume
- 48
- Issue
- 9
- Pages
- 2622-2631
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2413990098
- Cited by
- 268
- References
- 63
- FWCI
- 11.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.